Printer friendly

What does IEOM stand for?

IEOM stands for Inborn Errors of Metabolism (molecular biology)

This definition appears rarely and is found in the following Acronym Finder categories:

  • Science, medicine, engineering, etc.

See other definitions of IEOM

Other Resources:
We have 1 other meaning of IEOM in our Acronym Attic

Samples in periodicals archive:

The hospital was chosen to host the Society for the International Inborn Errors of Metabolism (SSIEM) conference as it is the UK's leading centre for research and treatment, seeing around 1,000 patients every year from across the UK and overseas.
Summary: ABU DHABI -- Health experts from across the globe have convened during the weekend for an intensive workshop and lectures tackling the importance of medical nutrition in the treatment in key diseases including cancer, diabetes, epilepsy, inborn errors of metabolism, faltering growth and allergy, and general malnutrition.
True (A) or false (B): Unexplained jaundice in the neonatal period is a feature of the clinical presentation of inborn errors of metabolism in the neonatal period.
9), the first relation between a genetic defect and a biochemical abnormality was reported in the study of the human disease alkaptonuria by Archibald Garrod in his book Inborn Errors of Metabolism (1909).
The future is bright for the Vitaflo business, its staff and Liverpool as a centre of excellence for the development of products for inborn errors of metabolism and disease related malnutrition.
The have organized the papers into sections that focus in turn on: chemistry, biochemistry, and the formation and reactivity of endogenous toxins such as metabolic intermediates and reactive oxygen species, particularly those associated with excessive sugar, fat, meat, or alcohol consumption; the association of increased endogenous toxin levels with inborn errors of metabolism such as galactosemia, hyperlipidemia, porphyria, hemochromatosis, and related conditions; examples of endogenous toxins that appear to be associated with acquired diseases or animal disease models, including hepatic injury, asthma, rheumatism, colorectal cancer, reperfusion diseases, neurodegeneration, and aging; and nutritional and pharmacologic therapeutics that have been proposed for decreasing endogenous toxins.